{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:41:50Z","timestamp":1759459310238,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1053\/j.ajkd.2014.04.015","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T17:45:47Z","timestamp":1399743947000},"page":"492-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug-Drug Interactions and Acute Kidney Injury: Caveat Prescriptor"],"prefix":"10.1053","volume":"64","author":[{"given":"Mallika L.","family":"Mendu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushrut S.","family":"Waikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2014.04.015_bib1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.47102\/annals-acadmedsg.V38N12p1095","article-title":"Drug use and dosing in chronic kidney disease","volume":"38","author":"Hassan","year":"2009","journal-title":"Ann Acad Med Singapore"},{"key":"10.1053\/j.ajkd.2014.04.015_bib2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.2013.399","article-title":"Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport","volume":"85","author":"Yeung","year":"2014","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.04.015_bib3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2014.04.015_bib4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ki.2011.322","article-title":"Drug dosing consideration in patients with acute and chronic kidney disease\u2014a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Matzke","year":"2011","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.04.015_bib5","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2013.282426","article-title":"Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury","volume":"310","author":"Gandhi","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2014.04.015_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","article-title":"The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register","volume":"30","author":"Johnell","year":"2007","journal-title":"Drug Saf"},{"key":"10.1053\/j.ajkd.2014.04.015_bib7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2014.04.015_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007890-199301000-00010","article-title":"A\u00a0study of treatment compliance following kidney transplantation","volume":"55","author":"Kiley","year":"1993","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2014.04.015_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002857","article-title":"Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions","volume":"3","author":"Fleet","year":"2013","journal-title":"BMJ Open"},{"key":"10.1053\/j.ajkd.2014.04.015_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1345\/aph.1E432","article-title":"Clarithromycin-nifedipine interaction as possible cause of vasodilatory shock","volume":"39","author":"Geronimo-Pardo","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.ajkd.2014.04.015_bib11","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/ajhp\/55.22.2417","article-title":"Severe hypotension and bradycardia associated with verapamil and clarithromycin","volume":"55","author":"Kaeser","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.ajkd.2014.04.015_bib12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/106002809102500918","article-title":"Erythromycin-felodipine interaction","volume":"25","author":"Liedholm","year":"1991","journal-title":"DICP"},{"key":"10.1053\/j.ajkd.2014.04.015_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1345\/aph.1E496","article-title":"Verapamil toxicity resulting from a probable interaction with telithromycin","volume":"39","author":"Reed","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.ajkd.2014.04.015_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1503\/cmaj.100702","article-title":"The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers","volume":"183","author":"Wright","year":"2011","journal-title":"CMAJ"},{"key":"10.1053\/j.ajkd.2014.04.015_bib15","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-158-12-201306180-00004","article-title":"Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study","volume":"158","author":"Patel","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2014.04.015_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2011.07.022","article-title":"Use of clinical decision support systems for kidney-related drug prescribing: a systematic review","volume":"58","author":"Tawadrous","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2014.04.015_bib17","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.286.22.2839","article-title":"Guided medication dosing for inpatients with renal insufficiency","volume":"286","author":"Chertow","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2014.04.015_bib18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/j.ajkd.2010.05.024","article-title":"A\u00a0computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report","volume":"56","author":"McCoy","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2014.04.015_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00228-012-1338-y","article-title":"Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care","volume":"69","author":"Andersson","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2014.04.015_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11096-012-9642-2","article-title":"Evaluation of drug-drug interaction screening software combined with pharmacist intervention","volume":"34","author":"Moura","year":"2012","journal-title":"Int J Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2014.04.015_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjopharm.2011.09.006","article-title":"Detection and prevention of drug-drug\u00a0interactions in the hospitalized elderly: utility of new cytochrome P450-based software","volume":"9","author":"Zakrzewski-Jakubiak","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1053\/j.ajkd.2014.04.015_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/amiajnl-2012-001073","article-title":"Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting","volume":"20","author":"Duke","year":"2013","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1053\/j.ajkd.2014.04.015_bib23","doi-asserted-by":"crossref","first-page":"e85071","DOI":"10.1371\/journal.pone.0085071","article-title":"Are we heeding the warning signs? Examining providers' overrides of computerized drug-drug interaction alerts in primary care","volume":"8","author":"Slight","year":"2013","journal-title":"PloS One"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614007975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614007975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:25:51Z","timestamp":1759458351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638614007975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0272638614007975"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.04.015","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Drug Interactions and Acute Kidney Injury: Caveat Prescriptor","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}